Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
July-2016 Volume 36 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2016 Volume 36 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo

  • Authors:
    • Xiaofeng Yang
    • Fan Zhang
    • Junqian Luo
    • Jianzhi Pang
    • Sanhua Yan
    • Fang Luo
    • Jiehao Liu
    • Wei Wang
    • Yongping Cui
    • Xixi Su
  • View Affiliations / Copyright

    Affiliations: Department of Urology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Shanxi Medical University, Graduate School, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
    Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 79-89
    |
    Published online on: May 23, 2016
       https://doi.org/10.3892/or.2016.4829
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Bladder cancer is common and widespread, and its incidence is increasing. Many new diagnostic methods combined with state-of-the-art technology have been introduced in cystoscopy to collect real-time images of the bladder mucosa for diagnosis, but often miss inconspicuous early-stage tumors. Fluorophore-labeled peptides with high sensitivity and specificity for cancer would be a desirable tool for the detection and treatment of tiny or residual bladder tumors. Phage display and the human non-muscle-invasive bladder cancer cell line BIU-87 were used to identify a peptide. The isolated phage display peptide (CSSPIGRHC, named NYZL1) was tested in vitro for its binding specificity and affinity. Accumulation into xenograft tumors in a nude mouse model was analyzed with FITC-labeled NYZL1. NYZL1, with strong tumor‑homing ability, was identified by in vivo phage library selection in the bladder cancer model. The NYZL1 phage and synthetic FITC-labeled NYZL1 peptides bound to tumor tissues and cells, but were hardly detected in normal control organs. Notably, accumulation of FITC-NYZL1 in bladder tumor cells was time-dependent. Biodistribution studies of xenografts of BIU-87 cells showed accumulation of injected FITC-NYZL1 in the tumors, and the bound peptide could not be removed by perfusion after 24 h. The mouse model of bladder tumor showed increased fluorescence intensity in the tumor-bearing bladder in comparison with normal bladder tissues after 4-6 h. In conclusion, NYZL1 may represent a lead peptide structure applicable in the development of optical molecular imaging.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Ploeg M, Aben KK and Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A and Palou-Redorta J: European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 54:303–314. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, et al: Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology. 66(Suppl 1): S4–S34. 2005. View Article : Google Scholar

4 

Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW and Kurth K: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 49:466–477. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr and Schellhammer PF: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 178:2314–2330. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Botteman MF, Pashos CL, Redaelli A, Laskin B and Hauser R: The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics. 21:1315–1330. 2003. View Article : Google Scholar

7 

Riley GF, Potosky AL, Lubitz JD and Kessler LG: Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 33:828–841. 1995. View Article : Google Scholar : PubMed/NCBI

8 

Liu JJ, Droller MJ and Liao JC: New optical imaging technologies for bladder cancer: Considerations and perspectives. J Urol. 188:361–368. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Weissleder R: Molecular imaging in cancer. Science. 312:1168–1171. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Kwon YS, Cho YS, Yoon TJ, Kim HS and Choi MG: Recent advances in targeted endoscopic imaging: Early detection of gastrointestinal neoplasms. World J Gastrointest Endosc. 4:57–64. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Mahmood U and Wallace MB: Molecular imaging in gastrointestinal disease. Gastroenterology. 132:11–14. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Cheng L, Davison DD, Adams J, Lopez-Beltran A, Wang L, Montironi R and Zhang S: Biomarkers in bladder cancer: Translational and clinical implications. Crit Rev Oncol Hematol. 89:73–111. 2014. View Article : Google Scholar

13 

Muguruma N, Miyamoto H, Okahisa T and Takayama T: Endoscopic molecular imaging: Status and future perspective. Clin Endosc. 46:603–610. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Vlieghe P, Lisowski V, Martinez J and Khrestchatisky M: Synthetic therapeutic peptides: Science and market. Drug Discov Today. 15:40–56. 2010. View Article : Google Scholar

15 

Lee SM, Lee EJ, Hong HY, Kwon MK, Kwon TH, Choi JY, Park RW, Kwon TG, Yoo ES, Yoon GS, et al: Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res. 5:11–19. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Zhang H, Aina OH, Lam KS, de Vere White R, Evans C, Henderson P, Lara PN, Wang X, Bassuk JA and Pan CX: Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol. 30:635–645. 2012. View Article : Google Scholar

17 

Gautam A, Kapoor P, Chaudhary K, Kumar R and Raghava GP and Raghava GP: Open Source Drug Discovery Consortium: Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics. Curr Med Chem. 21:2367–2391. 2014. View Article : Google Scholar

18 

Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, et al: European Association of Urology: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013. Eur Urol. 64:639–653. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Geavlete B, Jecu M, Multescu R, Georgescu D and Geavlete P: HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer - re-TURBT recurrence rates in a prospective, randomized study. Urology. 76:664–669. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Smith GP: Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science. 228:1315–1317. 1985. View Article : Google Scholar : PubMed/NCBI

21 

Li M, Gu FL, Li WB, Song YS, Zhou AR and Guo YL: Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells. Urol Res. 23:311–314. 1995. View Article : Google Scholar : PubMed/NCBI

22 

Zhou HL, Zheng YJ, Cheng XZ, Lv YS, Gao R, Mao HP and Chen Q: Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact. J Urol. 190:1069–1075. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Chen J, Ou-Yang X, Gao J, Zhu J, He X and Rong J: Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials. Mol Cell Biochem. 349:83–95. 2011. View Article : Google Scholar

24 

Fridman R, Benton G, Aranoutova I, Kleinman HK and Bonfil RD: Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection. Nat Protoc. 7:1138–1144. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Lewis MT, Landua JD, Adams HC III and Medina D: A mystery wrapped in an enigma: Matrigel enhancement of mammary cell growth and morphogenesis. J Mammary Gland Biol Neoplasia. 17:99–101. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Green MR and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press; New York: 2012

27 

Koivistoinen A, Ilonen II, Punakivi K, Räsänen JV, Helin H, Sihvo EI, Bergman M and Salo JA: A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display. Clin Transl Oncol. 15:492–498. 2013. View Article : Google Scholar

28 

Zhang L, Giraudo E, Hoffman JA, Hanahan D and Ruoslahti E: Lymphatic zip codes in premalignant lesions and tumors. Cancer Res. 66:5696–5706. 2006. View Article : Google Scholar : PubMed/NCBI

29 

Pilch J, Brown DM, Komatsu M, Järvinen TA, Yang M, Peters D, Hoffman RM and Ruoslahti E: Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci USA. 103:2800–2804. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Horton DA, Bourne GT and Smythe ML: Exploring privileged structures: The combinatorial synthesis of cyclic peptides. J Comput Aided Mol Des. 16:415–430. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Pasqualini R and Ruoslahti E: Organ targeting in vivo using phage display peptide libraries. Nature. 380:364–366. 1996. View Article : Google Scholar : PubMed/NCBI

32 

Essler M and Ruoslahti E: Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA. 99:2252–2257. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Kolonin MG, Saha PK, Chan L, Pasqualini R and Arap W: Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 10:625–632. 2004. View Article : Google Scholar : PubMed/NCBI

34 

Arap W, Pasqualini R and Ruoslahti E: Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:377–380. 1998. View Article : Google Scholar : PubMed/NCBI

35 

Craik DJ, Fairlie DP, Liras S and Price D: The future of peptide-based drugs. Chem Biol Drug Des. 81:136–147. 2013. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang X, Zhang F, Luo J, Pang J, Yan S, Luo F, Liu J, Wang W, Cui Y, Su X, Su X, et al: A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo . Oncol Rep 36: 79-89, 2016.
APA
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F. ... Su, X. (2016). A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo . Oncology Reports, 36, 79-89. https://doi.org/10.3892/or.2016.4829
MLA
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F., Liu, J., Wang, W., Cui, Y., Su, X."A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo ". Oncology Reports 36.1 (2016): 79-89.
Chicago
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F., Liu, J., Wang, W., Cui, Y., Su, X."A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo ". Oncology Reports 36, no. 1 (2016): 79-89. https://doi.org/10.3892/or.2016.4829
Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Zhang F, Luo J, Pang J, Yan S, Luo F, Liu J, Wang W, Cui Y, Su X, Su X, et al: A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo . Oncol Rep 36: 79-89, 2016.
APA
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F. ... Su, X. (2016). A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo . Oncology Reports, 36, 79-89. https://doi.org/10.3892/or.2016.4829
MLA
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F., Liu, J., Wang, W., Cui, Y., Su, X."A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo ". Oncology Reports 36.1 (2016): 79-89.
Chicago
Yang, X., Zhang, F., Luo, J., Pang, J., Yan, S., Luo, F., Liu, J., Wang, W., Cui, Y., Su, X."A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo ". Oncology Reports 36, no. 1 (2016): 79-89. https://doi.org/10.3892/or.2016.4829
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team